HUBUNGAN TINGKAT KEPATUHAN MINUM OBAT ANTIHIPERTENSI DAN OBESITAS TERHADAP TEKANAN DARAH PENDERITA HIPERTENSI

DOI: https://doi.org/10.31596/cjp.v7i2.250

Nur Islahuddin Aly(1), Annik Megawati(2*)

(1) Institut Teknologi Kesehatan Cendekia Utama Kudus
(2) Institut Teknologi Kesehatan Cendekia Utama Kudus
(*) Corresponding Author

Abstract


Hypertension is the most common disease that affects around 40% of the adult population worldwide and is called the silent killer. Compliance with taking prescription drugs is very necessary to avoid the risk of complications and minimize medical expenses. Improved adherence will provide maximum benefit from the prescribed medication and this is one simple strategy in the management of hypertension. Non- compliance with the use of anti-hypertensive drugs and obesity will be detrimental to the patient itself and is a factor that causes the failure of therapy being undertaken. The purpose of this study was to determine the relationship between the level of adherence to taking antihypertensive and obesity drugs to blood pressure in hypertensive patients. This type of research was observational analytic with cross sectional approach using total sampling of 67 respondents. The instruments used were questionnaires and calibrated instruments namely mercury sphygmomanometer, stethoscope and stature meter and digital scales. Statistical tests used Chi Square with a significance level of ? = 0.05 or 95%. Multivariate analysis using binary regression analysis. Obtained p value = 0,000 (p<0.05) from the level of adherence to taking antihypertensive and obesity drugs to blood pressure in patients with hypertension. The magnitude of the influence of patients with hypertension who are obedient in taking high category drugs has a controlled blood pressure of 6,857 times compared to patients with obedient hypertension who take low medication. While the magnitude of the influence of patients with hypertension who are obese I have controlled blood pressure as much as 5,558 times compared to patients with obesity hypertension II. There is a significant relationship between the level of adherence to taking anti-hypertensive and obesity drugs to blood pressure in hypertensive patients


Keywords


Hypertension; Antihypertensive Drug; Adherence Level; and Obesity

Full Text:

PDF

Article Metrics

Abstract viewed : 134 times | PDF files downloaded : 108 times

References


Amanda, D., & Martini, S. (2018). The Relationship between Demographical Characteristic and Central Obesity with Hypertension. Jurnal Berkala Epidemiologi, 6(1), 43.

Brown, M. T., & Bussell, J. K. (2011). Medication adherence: WHO cares? Mayo Clinic Proceedings, 86(4), 304–314.

Dinas Kesehatan Kabupaten Pati. (2016). Profil Kesehatan Kabupaten Pati 2016, 34.

Dinas Kesehatan Provinsi Jawa Tengah. (2016). Profil Kesehatan Provinsi Jawa Tengah Tahun 2016, 59.

Egan, B. M., Zhao, Y., Li, J., Brzezinski, W. A., Todoran, T. M., Brook, R. D., & Calhoun, D. A. (2013). Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. AHA Journals, 62(4), 691–697.

Gama, I. K. (2014). Faktor penyebab ketidakpatuhan kontrol penderita hipertensi. Jurnal Gema Keperawatan.

Hardiyanti, Amiruddin, R., & Masni. (2016). Kepatuhan Minum Obat Terhadap Status Hipertensi Di Wilayah Kerja Puskesmas Bajoe Kabupaten Bone Tahun 2016. JST Kesehatan, 6(2252–5416), 375–380.

Hasanah, M., Widodo, D., & Widiani, E. (2016). Hubungan Obesitas Dengan Hipertensi Pada Masyarakat Di Wilayah Rw 13 Dusun Mojosari Desa Ngenep Kecamatan Karangploso. Nursing News, 1(2), 35–44.

Kemenkes, B. P. dan P. K. (2013). Laporan Riset Kesehatan Dasar 2013, 111– 116.

Kurniapuri, A., & Supadmi, W. (2015). Pengaruh Pemberian Informasi Obat Antihipertensi Terhadap Kepatuhan Pasien Hipertensi Di Puskesmas Umbulharjo I Yogyakarta Periode November 2014. Majalah Farmaseutik, 11(1), 268–274.

Liberty, I. A., Pariyana, Roflin, E., & Waris, L. (2017). Determinan Kepatuhan Berobat Pasien Hipertensi pada Fasilitas Kesehatan Tingkat I Berdasarkan anjuran Joint National. Jurnal Penelitian Dan Pengembangan Pelayanan Kesehatan, 58–65.

Rohkuswara, T. D., & Syarif, S. (2017). Hubungan Obesitas dengan Kejadian Hipertensi Derajat 1 di Pos Pembinaan Terpadu Penyakit Tidak Menular (Posbindu PTM) Kantor Kesehatan Pelabuhan Bandung Tahun 2016. Jurnal Epidemiologi Kesehatan Indonesia, 1(2), 13–18.

Sinuraya, R. K., Destiani, D. P., Puspitasari, I. M., & Diantini, A. (2018). Medication Adherence among Hypertensive Patients in Primary Healthcare in Bandung City. Indonesian Journal of Clinical Pharmacy, 7(2), 124–133.

Siyad. (2011). Hypertension. Journal For Drugs And Medicines, 3(1), 1–16.

South Andrew, MD, Nixon Patricia, PhD, Chappell Mark, PhD, Diz Debra, PhD, Russell Gregory, MS, Shaltout Hossam, PhD, O’Shea T, MD, and Washburn Lisa, M. (2017). Original articles. The Journal of Pediatrics, 0–6.

Vidal-Petiot, E., Elbez, Y., Lüscher, T. F., Fox, K. M., & Steg, P. G. (2018). The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients. European Heart Journal, (August), 1–2.

Wahyuddin, D., & Andajani, S. (2016). Hipertensi pada Laki-Laki Usia 40 Tahun ke Atas. Jurnal Wiyata, 119–125.




DOI: https://doi.org/10.31596/cjp.v7i2.250

Refbacks

  • There are currently no refbacks.


Journal Indexed by:

Google Scholar OneSearch Garuda Ristekdikti PKP Index Crossref

Copyright of Cendekia Journal of Pharmacy. ISSN: 2599-2163 (Print) dan 2599-2155 (Online).

Creative Commons License
This work is licensed under a Creative Commons Attribution 2.0 Generic License. Web
Analytics View My Stats